Clinical Trials Browser

Phase 1 × lorvotuzumab mertansine × Gynecologic × Clear all

NCT00346385 2015-03-26

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

DermatologicGynecologicThoracic

Ovarian Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma